The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.

However, when using Cramer's Phi as effect size parameter, relevant associations between COR week 5 improvement and clinical outcome (response rate, remission rate) could be shown for the reboxetine group which were nearly significant (response rate: Phi = 0.435; p = 0.052; remission rate: Phi = 0.546; p = 0.051), whereas no such association were seen in the mirtazapine group ( Table 3 ).

also in 3,349 other papers